Jun Yoon

Title: Jun Yoon: Innovator in Chimeric Antigen Receptors

Introduction

Jun Yoon is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs). His innovative work focuses on enhancing the effectiveness of targeted therapies.

Latest Patents

Jun Yoon holds a patent for "Fibronectin binding domain chimeric antigen receptors and methods of use thereof." This patent describes CARs designed for binding with target antigens, which include at least one antigen-specific targeting region comprising a fibronectin type 3 (FN3) domain polypeptide. The invention also encompasses multispecific CARs that can bind with two or more target antigens, providing a versatile approach to treatment. The compositions and methods outlined in this patent have the potential to advance therapeutic strategies in various medical applications.

Career Highlights

Jun Yoon is currently associated with Protelica, Inc., where he continues to innovate in the field of CAR technology. His work is instrumental in developing new therapeutic options for patients, particularly in oncology and immunotherapy.

Collaborations

Jun Yoon collaborates with esteemed colleagues, including Roberto Crea and Craig A Hokanson. Their combined expertise contributes to the advancement of CAR technology and its applications in medicine.

Conclusion

Jun Yoon's contributions to the field of chimeric antigen receptors exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Protelica, Inc. highlight the importance of targeted therapies in modern medicine.